Demonstration/NN
of/IN
estrogen/NN
and/CC
progesterone/NN
receptors/NNS
as/RB
well/RB
as/IN
Ki-67/NN
and/CC
p-145/NN
antigens/NNS
in/IN
single/JJ
tumor/NN
cells/NNS
from/IN
blood/NN
and/CC
pleural/JJ
effusions/NNS
using/VBG
a/DT
slide/NN
assay/NN
./.

We/PRP
describe/VBP
a/DT
slide/NN
assay/NN
that/WDT
allows/VBZ
the/DT
demonstration/NN
of/IN
antigens/NNS
localized/JJ
in/IN
the/DT
nucleus/NN
from/IN
isolated/VBN
white/JJ
blood/NN
cells/NNS
as/RB
well/RB
as/IN
from/IN
single/JJ
tumor/NN
cells/NNS
derived/VBN
from/IN
malignant/JJ
effusions/NNS
./.
=====
With/IN
the/DT
antibodies/NNS
Ki-67/NN
and/CC
anti-p-145/NN
an/DT
increased/VBN
rate/NN
of/IN
nuclear/JJ
and/CC
nucleolar/JJ
staining/NN
resulted/VBD
in/IN
cells/NNS
from/IN
highly/RB
malignant/JJ
lymphomas/NNS
./.
=====
An/DT
almost/RB
identical/JJ
reaction/NN
was/VBD
obtained/VBN
when/WRB
tumor/NN
cells/NNS
from/IN
malignant/JJ
effusions/NNS
were/VBD
tested/VBN
./.
=====
Cells/NNS
isolated/VBN
from/IN
the/DT
blood/NN
of/IN
patients/NNS
with/IN
leukemic/JJ
spread/NN
of/IN
lymphomas/NNS
of/IN
low/JJ
malignancy/NN
yielded/VBD
a/DT
weak/JJ
staining/NN
comparable/JJ
to/TO
that/DT
of/IN
normal/JJ
mesothelial/JJ
cells/NNS
from/IN
non-tumorous/JJ
cavity/NN
fluids/NNS
./.
=====
The/DT
detection/NN
of/IN
estrogen/NN
and/CC
progesterone/NN
receptors/NNS
(/(
ER/NN
and/CC
PR/NN
)/)
localized/JJ
in/IN
the/DT
cell/NN
nucleus/NN
can/MD
be/VB
achieved/VBN
by/IN
the/DT
same/JJ
assay/NN
./.
=====
The/DT
reaction/NN
is/VBZ
enhanced/VBN
by/IN
incubation/NN
of/IN
the/DT
tumor/NN
cells/NNS
for/IN
30/CD
min/NN
at/IN
37/CD
degrees/NNS
C/NN
prior/RB
to/TO
fixation/NN
./.
=====
Pleural/JJ
effusions/NNS
from/IN
20/CD
patients/NNS
with/IN
breast/NN
cancer/NN
were/VBD
tested/VBN
./.
=====
ER/NN
was/VBD
positive/JJ
in/IN
13/CD
and/CC
PR/NN
was/VBD
positive/JJ
in/IN
12/CD
of/IN
the/DT
20/CD
samples/NNS
./.
=====
In/IN
5/CD
cases/NNS
there/EX
was/VBD
a/DT
divergent/JJ
reaction/NN
with/IN
ER/NN
and/CC
PR/NN
antibody/NN
./.
=====
The/DT
hormone/NN
receptors/NNS
of/IN
the/DT
primary/JJ
tumor/NN
were/VBD
known/VBN
in/IN
15/CD
(/(
ER/NN
)/)
and/CC
14/CD
(/(
PR/NN
)/)
patients/NNS
,/,
respectively/RB
./.
=====
In/IN
each/DT
cohort/NN
there/EX
was/VBD
only/RB
one/CD
case/NN
with/IN
a/DT
negative/JJ
reaction/NN
of/IN
the/DT
primary/JJ
tumor/NN
and/CC
a/DT
positive/JJ
reaction/NN
with/IN
the/DT
isolated/VBN
tumor/NN
cells/NNS
from/IN
the/DT
pleural/JJ
effusions/NNS
./.
=====
These/DT
results/NNS
indicate/VBP
that/IN
the/DT
demonstration/NN
of/IN
hormone/NN
receptor/NN
proteins/NNS
in/IN
cells/NNS
from/IN
malignant/JJ
effusions/NNS
is/VBZ
possible/JJ
and/CC
that/IN
there/EX
is/VBZ
a/DT
correlation/NN
with/IN
the/DT
status/NN
of/IN
the/DT
primary/JJ
site/NN
of/IN
cancer/NN
./.